About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 298598, 8 pages
http://dx.doi.org/10.1155/2013/298598
Research Article

Antigenicity and Immunogenicity of Rotavirus VP6 Protein Expressed on the Surface of Lactococcus lactis

Laboratorio de Inmunología y Virología (LIV), Universidad Nacional de Quilmes, Bernal, B1876BXD Buenos Aires, Argentina

Received 29 April 2013; Revised 25 June 2013; Accepted 9 July 2013

Academic Editor: Jose R. Botella

Copyright © 2013 L. E. Esteban et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. G. Bermúdez-Humarán, P. Kharrat, J.-M. Chatel, and P. Langella, “Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines,” Microbial Cell Factories, vol. 10, supplement 1, p. S4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Mierau and M. Kleerebezem, “10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis,” Applied Microbiology and Biotechnology, vol. 68, no. 6, pp. 705–717, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Le Loir, V. Azevedo, S. C. Oliveira et al., “Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production,” Microbial Cell Factories, vol. 4, no. 1, article 2, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Nouaille, L. A. Ribeiro, A. Miyoshi et al., “Heterologous protein production and delivery systems for Lactococcus lactis,” Genetics and Molecular Research, vol. 2, no. 1, pp. 102–111, 2003. View at Scopus
  5. B. Jiang, M. Patel, and U. Parashar, “Rotavirus vaccines for global use: what are the remaining issues and challenges?” Human Vaccines, vol. 6, no. 5, pp. 425–427, 2010. View at Scopus
  6. U. D. Parashar, J. P. Alexander, and R. I. Glass, “Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP),” MMWR. Recommendations and Reports, vol. 55, no. RR-12, pp. 1–13, 2006. View at Scopus
  7. R. L. Ward, M. M. McNeal, and A. D. Steele, “Why does the world need another rotavirus vaccine?” Therapeutics and Clinical Risk Management, vol. 4, no. 1, pp. 49–63, 2008. View at Scopus
  8. C. A. Perez, C. Eichwald, O. Burrone, and D. de Mendoza, “Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice,” Journal of Applied Microbiology, vol. 99, no. 5, pp. 1158–1164, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Marelli, A. R. Perez, C. Banchio, D. de Mendoza, and C. Magni, “Oral immunization with live Lactococcus lactis expressing rotavirus VP8* subunit induces specific immune response in mice,” Journal of Virological Methods, vol. 175, no. 1, pp. 28–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Rodríguez-Díaz, R. Montava, R. Viana, J. Buesa, G. Pérez-Martínez, and V. Monedero, “Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* protein,” Biotechnology Letters, vol. 33, no. 6, pp. 1169–1175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-J. Li, G.-P. Ma, G.-W. Li et al., “Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 708460, 9 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Enouf, P. Langella, J. Commissaire, J. Cohen, and G. Corthier, “Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic,” Applied and Environmental Microbiology, vol. 67, no. 4, pp. 1423–1428, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. K. Estes and A. Z. Kapikian, “Rotviruses,” in Fields Virology, B. N. Fields, D. M. Knipe, and P. M. Howley, Eds., Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2007.
  14. B. Tang, J. M. Gilbert, S. M. Matsui, and H. B. Greenberg, “Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis,” Virology, vol. 237, no. 1, pp. 89–96, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. A. H. Choi, M. M. McNeal, M. Basu et al., “Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses,” Vaccine, vol. 20, no. 27-28, pp. 3310–3321, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Maniatis, E. F. Fritsch, and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA, 1982.
  17. J. Gray and U. Desselberger, Rotaviruses Methods and Protocols, Humana Press, Totowa, NJ, USA, 2000.
  18. R. Boom, C. J. A. Sol, M. M. M. Salimans, C. L. Jansen, P. M. E. Wertheim-van Dillen, and J. van der Noordaa, “Rapid and simple method for purification of nucleic acids,” Journal of Clinical Microbiology, vol. 28, no. 3, pp. 495–503, 1990. View at Scopus
  19. Y. Dieye, S. Usai, F. Clier, A. Gruss, and J.-C. Piard, “Design of a protein-targeting system for lactic acid bacteria,” Journal of Bacteriology, vol. 183, no. 14, pp. 4157–4166, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Reuter, S. Hanniffy, and J. M. Wells, “Expression and delivery of heterologous antigens using lactic acid bacteria,” in Methods in Molecular Medicine: Vaccine Protocols, A. Robinson, M. J. Hudson, and M. P. Cranage, Eds., Humana Press Inc., Totowa, NJ, USA, 2003.
  21. G. A. Villegas, M. H. Argüelles, A. A. Castello, N. J. Mas, and G. Glikmann, “A rapid method to produce high yields of purified rotavirus particles,” Journal of Virological Methods, vol. 104, no. 1, pp. 9–19, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. P. M. Norton, H. W. G. Brown, J. M. Wells, A. M. Macpherson, P. W. Wilson, and R. W. F. Le Page, “Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis,” FEMS Immunology and Medical Microbiology, vol. 14, no. 2-3, pp. 167–177, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. K. K. Yam, F. Hugentobler, P. Pouliot et al., “Generation and evaluation of A2-expressing Lactococcus lactis live vaccines against Leishmania donovani in BALB/c mice,” Journal of Medical Microbiology, vol. 60, no. 9, pp. 1248–1260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Robinson, L. M. Chamberlain, M. C. Lopez et al., “Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C,” Infection and Immunity, vol. 72, no. 5, pp. 2753–2761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Robinson, L. M. Chamberlain, K. M. Schofield, J. M. Wells, and R. W. F. Le Page, “Oral vaccination of mice against tetanus with recombinant Lactococcus lactis,” Nature Biotechnology, vol. 15, no. 7, pp. 653–657, 1997. View at Scopus
  26. J. M. Wells, P. W. Wilson, P. M. Norton, M. J. Gasson, and R. W. F. Le Page, “Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge,” Molecular Microbiology, vol. 8, no. 6, pp. 1155–1162, 1993. View at Scopus
  27. J. W. Burns, M. Siadat-Pajouh, A. A. Krishnaney, and H. B. Greenberg, “Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity,” Science, vol. 272, no. 5258, pp. 104–107, 1996. View at Scopus
  28. B. Corthésy, Y. Benureau, C. Perrier et al., “Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion,” Journal of Virology, vol. 80, no. 21, pp. 10692–10699, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. C. Chen, E. F. Fynan, H. L. Robinson et al., “Protective immunity induced by rotavirus DNA vaccines,” Vaccine, vol. 15, no. 8, pp. 899–902, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. J. E. Herrmann, S. C. Chen, E. F. Fynan et al., “Protection against rotavirus infections by DNA vaccination,” Journal of Infectious Diseases, vol. 174, supplement 1, pp. S93–S97, 1996. View at Scopus
  31. A. H.-C. Choi, K. Smiley, M. Basu et al., “Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injection,” Vaccine, vol. 25, no. 16, pp. 3215–3218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. A. H.-C. Choi, M. Basu, M. M. McNeal, J. D. Clements, and R. L. Ward, “Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein,” Journal of Virology, vol. 73, no. 9, pp. 7574–7581, 1999. View at Scopus
  33. M. M. McNeal, M. Basu, J. A. Bean et al., “Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge,” Vaccine, vol. 25, no. 33, pp. 6224–6231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. J. W. Burns, A. A. Krishnaney, P. T. Vo, R. V. Rouse, L. J. Anderson, and H. B. Greenberg, “Analyses of homologous rotavirus infection in the mouse model,” Virology, vol. 207, no. 1, pp. 143–153, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. A. S. Laimbacher, L. E. Esteban, A. A. Castello, et al., “HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice,” Molecular Therapy, vol. 20, no. 9, pp. 1810–1820, 2012. View at Publisher · View at Google Scholar
  36. R. Ward, “Mechanisms of protection against rotavirus infection and disease,” Pediatric Infectious Disease Journal, vol. 28, no. 3, supplement, pp. S57–S59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Mierau, P. Leij, I. van Swam et al., “Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: the case of lysostaphin,” Microbial Cell Factories, vol. 4, article 15, 2005. View at Publisher · View at Google Scholar · View at Scopus